“Don’t eat me!” That’s how one might translate the signal that the cancer cells in a glioblastoma send to the macrophages (white blood cells specialized in removing dead and dying cellular matter) in the brain.
FDA approves Servier’s VORANIGO for IGrade 2 glioma
A once-daily oral medication, the asset acts as an inhibitor for both IDH1 and IDH2 enzymes. Credit: danilo.alvesd on Unsplash. The US Food and Drug
August 7, 2024